Centauri Therapeutics Series A

Centauri Therapeutics is a biotechnology company based in Alderley Park, UK, focused on the discovery and development of novel therapeutics for serious diseases. Leveraging its proprietary Alphamer® platform, the company develops immunotherapies that harness the body's natural immune response to fight life-threatening infections, particularly multi-drug resistant Gram-negative bacteria. The platform also has initial proof-of-concept data in oncology, expanding therapeutic options for vulnerable patients.